Related Experiment Video
Updated: Jul 4, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Galphaq binds two effectors separately in cells: evidence for predetermined signaling pathways
Urszula Golebiewska1, Suzanne Scarlata
1Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York 11794-8661, USA.
Abstract:
G-proteins transduce signals along diverse pathways, but the factors involved in pathway selection are largely unknown. Here, we have studied the ability of Galpha(q) to select between two effectors-mammalian inositide-specific phospholipase Cbeta (PLCbeta) and phosphoinositide-3-kinase (PI3K)-in human embryonic kidney 293 cells. These studies were carried out by measuring interactions between eCFP- and eYFP-tagged proteins using Forster resonance energy transfer in the basal state and during stimulation. Instead of association of Galpha(q) with effectors through diffusion and exchange, we found separate and stable pools of Galpha(q)-PLCbeta and Galpha(q)-PI3K complexes existing throughout the stimulation cycle. These separate complexes existed despite the ability of Galpha(q) to simultaneously bind both effectors as determined by in vitro measurements using purified proteins. Preformed G-protein/effector complexes will limit the number of pathways that a given signal will take, which may simplify predictive models.
Insights
G-protein pathway selection was studied using Galpha(q) and its effectors, phospholipase Cbeta (PLCbeta) and phosphoinositide-3-kinase (PI3K). Separate, stable G-protein/effector complexes form, limiting signal transduction pathways.
Area of Science:
- Cellular signaling
- Molecular biology
- Biochemistry
Background:
- G-proteins mediate diverse cellular signals, but pathway selection mechanisms remain unclear.
- Understanding how G-protein alpha subunits (Galpha) choose between effectors is crucial for deciphering signal transduction.
- Galpha(q) is known to interact with multiple downstream effectors, including PLCbeta and PI3K.
Purpose of the Study:
- To investigate the pathway selection mechanism of Galpha(q) between phospholipase Cbeta (PLCbeta) and phosphoinositide-3-kinase (PI3K).
- To determine if Galpha(q) forms distinct complexes with PLCbeta and PI3K in living cells.
- To elucidate the dynamics of G-protein/effector interactions during signal transduction.
Main Methods:
- Utilized human embryonic kidney 293 cells expressing eCFP- and eYFP-tagged proteins.
- Employed Förster resonance energy transfer (FRET) to measure protein-protein interactions in real-time.
- Performed in vitro binding assays with purified proteins to assess simultaneous effector binding.
Main Results:
- Identified separate and stable complexes of Galpha(q)-PLCbeta and Galpha(q)-PI3K throughout the stimulation cycle.
- Observed that these complexes form independently and do not appear to involve diffusion and exchange.
- Demonstrated that Galpha(q) can simultaneously bind both PLCbeta and PI3K in vitro, despite forming separate complexes in cells.
Conclusions:
- Pre-formed G-protein/effector complexes dictate pathway usage, rather than dynamic exchange.
- This complex formation limits the number of signaling pathways activated by a single G-protein.
- Findings simplify predictive models of G-protein-mediated signal transduction.
Related Concept Videos
Activation and Inactivation of G Proteins
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway
G-protein Coupled Receptors

